Skip to main content
. Author manuscript; available in PMC: 2020 Jul 27.
Published in final edited form as: J Pharm Biomed Anal. 2019 Jun 20;174:541–551. doi: 10.1016/j.jpba.2019.06.025

Fig. 4.

Fig. 4.

The disturbed pathway of CG patients (left) and enrichment of the biomarkers related to CG. The color and size of each circle is based on P value and pathway impact value respectively. 1: Purine metabolism 2:Aminoacyl-tRNA biosynthesis 3: Caffeine metabolism 4: Alanine, aspartate and glutamate metabolism 5: Sphingolipid metabolism 6: Valine, leucine and isoleucine biosynthesis 7: Arginine and proline metabolism.